The present invention relates to absorbent articles comprising species of glyceride copolymers that provide unexpectedly improved softening performance and formulability.

The present invention is related to the field of tissue regeneration. It concerns more particularly new processes, tubes and devices for thrombin, platelet concentrate and wound healant preparations, alone or in combination with cell extracts, cell compositions and uses thereof.

An improved glove-shaped dressing for hands is presented which enables quicker wound closure and a lower anesthesia requirement, comprised of two hand-shaped pieces of an improved prior-art skin-substitute brought together with a sealing means and fitted to the hand with surgical staples.

The method of treating diabetic wounds using biosynthesized nanoparticles includes administering an effective amount of silver and gold nanoparticles to a patient in need thereof. The silver and gold nanocomposite is prepared by biosynthesis, i.e., by providing a first aqueous solution of a noble metal salt or a noble metal oxide; providing a second solution of an aqueous plant extract, and combining the first solution and the second solution to produce a solution including nanoparticles of the noble metal. The second solution includes a plant extract obtained from Solenostemma argel, Trigonella foenum-graecum and Cinnamomum cassia. The metal salt can include silver nitrate (AgNO.sub.3) and chloroauric acid (HAuCl.sub.4). Nanoparticles of gold and nanoparticles of silver are prepared separately, and then mixed to obtain a composition containing a gold and silver nanocomposite.

Burn wound compositions containing leaf lard, yellow beeswax, Oil of Spike, pine rosin, and aloe vera are described for treatment of first, second, and third degree burn wounds.

A therapeutic material or pharmaceutical is composed of 1) amniotic membranes in a large intact sheet, 2) lysates of intact sheets of amniotic membrane, or 3) the non-particulate fluids produced while creating lysates of intact sheets of amniotic membrane. Any of the embodiments of the therapeutic material can be formed with or without the incorporation of complex chemicals like hyaluronic acid and/or honey and/or additional therapeutic cells. The device or fluid is used to treat diseased tissue. Lysates of the amniotic membrane can be formed into any desirable shape, and then dehydrated, to maintain the desired 3D form of the device.

A biomaterial including a porous biocompatible structure having interconnected pores, wherein the pores have interior walls and are interconnected by passageways, the interior walls and passageways being coated with an osteoinductive aqueous demineralized bone extract solution, the aqueous demineralized bone extract solution including growth factors, proteins, a demineralized bone matrix and at least one of a weak acid and a guanidine hydrochloride, wherein the demineralized bone matrix is present per 100 g of the solution in an amount of from about 2 g to about 10 g.

The present disclosure relates a modified SIS membrane for tissue repair, a preparation method therefor and a use thereof. Specifically provided are a composition comprising a fusion polypeptide-modified SIS membrane and an extracellular vesicle, as well as a preparation method for and a use of the composition. It is proved that the fusion polypeptide-mediated SIS membrane and the composition containing the SIS membrane and the extracellular vesicle have excellent biological functions, and provide a broad prospect for treating bone defects or facilitating tissue healing or bone regeneration.

The subject invention provides topical therapeutic compositions and methods of their use for enhanced healing of wounds, including burns, and scars of the skin. Specifically, in one embodiment, the subject invention provides materials and methods for reducing the healing time of skin wounds and for reducing the appearance of scars. The subject invention utilizes topical compositions comprising microbial growth by-products and, optionally, a topically-acceptable carrier. In specific embodiments, the microbial growth by-products are biosurfactants.

An improved skin substitute is presented comprised of a silicone layer backed up with a woven nylon fabric layer, the silicone layer possessing a regular pattern of slits that permit the porosity of the skin substitute to be adjusted by clinicians by means of applying tension to the skin substitute that differentially opens the slits. A variety of therapeutic substances can be applied to the skin substitute to promote healing, including aloe and other medicinal preparations. The skin substitute is directed at chronic wound treatment and hernia repair.